Afatinib

Anti-PAK5 p21 (RAC1) activated kinase 5, 25ul UN 1687 6.1 PG

Anti-SLTM SAFB-like, transcription modulator, 25ul UN 1687 6

Anti-ULK1 unc-51 like autophagy activating kinase 1, 25ul UN

Anti-ULK4 unc-51 like kinase 4, 100ul UN 1687 6.1 PG2

Anti-ULK4 unc-51 like kinase 4, 25ul UN 1687 6.1 PG2

A cell-permeable, beta-lactone acyl protein thioesterase 1 (APT1) inhibitor (IC 50 = 0.67 &#181M, in an enzymatic assay) that is shown to specifically block Ras depalmitoylation, without affecting Ras acylation, in MDCK cells, both in vitro and in

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.product description：A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.product description：A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.product description：A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.product description：A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive

InformationAST5902 is the principal metabolite of alflutinib both in vitro and in vivo, which exerts remarkable antineoplastic activity similar to alflutinib. AST5902 exhibits much weak CYP3A4 induction potential compared to alflutinib.

Casein Kinase inhibitor A86 is a potent and orally active casein kinase 1α (CK1α) inhibitor. Casein Kinase inhibitor A86 also inhibits of CDK7 (TFIIH) and CDK9 (P-TEFb) . Casein Kinase inhibitor A861 induces leukemia cell apoptosis , and has potent